TON - August 2023 Vol 16, No 4

I am pleased to present the August issue of The Oncology Nurse-APN/ PA, a journal specifically designed for nurses, navigators, and advanced practice providers who work tirelessly to improve the lives of patients with cancer. Read More ›

Hunterdon Regional Cancer Center, Flemington, NJ, is a community-based cancer center offering an integrative approach to care, with access to prevention initiatives and screening as well as comprehensive diagnosis and treatment. Read More ›

Cancers and tumors of the appendix are extremely rare, with an estimated incidence of 0.15 to 0.9 per 100,000 people. The average age of onset is between 50 and 55 years, and the disease appears to affect men and women equally. Evidence suggests that the incidence of appendix cancer has increased over the past 2 decades. Read More ›

This section provides a brief overview of new cancer drugs and new indications approved by the FDA between May 19, 2023, and June 20, 2023. Read More ›

Chicago, IL—The presidential theme for the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting was “Partnering With Patients: The Cornerstone of Clinical Care and Research.” In his address during the opening session of the meeting, Eric P. Winer, MD, FASCO, ASCO’s 2022-2023 President, discussed the importance of physician–patient partnerships for improving healthcare outcomes. Read More ›

Chicago, IL—Interim results from the phase 3 COMMANDS trial demonstrated that first-line treatment with luspatercept-aamt (Reblozyl) increased hemoglobin levels and enabled nearly twice as many patients with transfusion-dependent, lower-risk myelodysplastic syndromes (MDS) to avoid red blood cell transfusions during the first 24 weeks of the study compared with standard-of-care epoetin alfa. Read More ›

Chicago, IL—The addition of the PD-1 inhibitor pembrolizumab (Keytruda) to chemotherapy with or without bevacizumab (Avastin) resulted in a substantial and clinically meaningful improvement in overall survival (OS) in patients with persistent, recurrent, or metastatic cervical cancer, according to the final OS analysis of the phase 3 KEYNOTE-826 trial. Read More ›

Nutrition is of growing interest to patients as part of a holistic approach to their cancer care and is an important topic for patients and caregivers to consider following a cholangiocarcinoma (CCA) diagnosis. At the 10th Annual Cholangiocarcinoma Foundation Conference, Stephanie Roit, MS, RD, CDN, CSO, Outpatient Oncology Dietitian, New York-Presbyterian Hospital, New York City, and caregiver Anita Benson highlighted important considerations and personal experiences with proper nutrition in managing patients with CCA. Read More ›

Updated results from a large clinical trial confirm that, for some patients with bladder cancer that can be removed with surgery, receiving immunotherapy immediately afterwards is an effective treatment. Read More ›

Artificial intelligence (AI)-powered medical treatment options are on the rise and have the potential to improve diagnostic accuracy, but a new study led by University of Arizona Health Sciences researchers found that approximately 52% of participants would choose a human doctor rather than AI for diagnosis and treatment. Read More ›